Pediatric granulomatous arthritis: An international registry
Open Access
- 28 September 2006
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 54 (10), 3337-3344
- https://doi.org/10.1002/art.22122
Abstract
Objective Blau syndrome and its sporadic counterpart, early-onset sarcoidosis, share an identical phenotype featuring the classic triad of arthritis, dermatitis, and uveitis and are associated with mutations of CARD15 in 50–90% of cases. We chose the term “pediatric granulomatous arthritis” to refer to both. An international registry was established in the spring of 2005 to define the phenotype spectrum and establish the mutation frequency and variants. Methods Histologically confirmed granuloma and arthritis were required for inclusion. Probands and relatives were genotyped for CARD15. Deidentified clinical information was collected. Results One year after the inception of the registry, 61 individuals from 22 pedigrees had been entered. Seven pedigrees with 19 individuals (8 affected, 11 unaffected) had clinical disease that was atypical, and none of the individuals in those pedigrees showed mutations. There were 9 classic simplex pediatric granulomatous arthritis pedigrees including 19 individuals (9 affected, 10 unaffected) and 6 classic multiplex pedigrees with 22 individuals (17 affected, 5 unaffected). Cutaneous presentation was the most common. Arthritis was polyarticular in 96% of patients. Isolated eye disease was never the presenting symptom, but significant/severe visual impairment was observed in 41% of patients. Eye disease was bilateral in 21 of 22 patients and was complicated by glaucoma in 6 of 22 patients and by cataracts in 50% of patients. Skin biopsy was the best diagnostic approach (because of accuracy and low invasiveness). Conclusion In this series, the first combining familial and sporadic pedigrees and, to our knowledge, the largest, we further defined the phenotype and showed that all affected classic (and no nonclassic) pedigrees carry a mutation and that there is no asymptomatic carriage. If these data are confirmed, mutation analysis rather than tissue sampling may prove to be the most efficient diagnostic procedure.Keywords
This publication has 20 references indexed in Scilit:
- A new CARD15 mutation in Blau syndromeEuropean Journal of Human Genetics, 2005
- Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor- B activation: common genetic etiology with Blau syndromeBlood, 2004
- Presence of a Sporadic Case of Systemic Granulomatosis Syndrome with a CARD15 MutationJournal of Investigative Dermatology, 2004
- CARD15 mutations in familial granulomatosis syndromes: A study of the original Blau syndrome kindred and other families with large‐vessel arteritis and cranial neuropathyArthritis & Rheumatism, 2002
- CARD15 mutations in Blau syndromeNature Genetics, 2001
- Nod2, a Nod1/Apaf-1 Family Member That Is Restricted to Monocytes and Activates NF-κBJournal of Biological Chemistry, 2001
- Overview and report on international registry of sarcoid arthritis in childhoodCurrent Rheumatology Reports, 2000
- Familial granulomatous arthritis, iritis, and rashThe Journal of Pediatrics, 1985
- Familial granulomatous synovitis, uveitis, and cranial neuropathiesThe American Journal of Medicine, 1985
- Sarcoid arthritis in childrenThe American Journal of Medicine, 1970